By Debdeep Gupta | April, 24 2026
Sun Pharma moves ahead with $13 billion Organon bid amid global expansion push: Report
dilip shanghvi is moving ahead with what could become his biggest deal yet, with a binding offer of nearly $13 billion submitted for us-based organon & co, an economic times report said on friday. the proposed acquisition is part of sun pharmaceutical industries' broader push to evolve from an indian generics leader into a global branded and innovation-driven drugmaker.sun pharma, india's largest drugmaker by revenue and market value, is said to







